This study evaluated molecular and ultrastructural adaptations in experimental progressive heart failure, and analyzed the effects of a combined inhibition of the renin-angiotensin system and neprilysin (RAS-/NEP-inhibition) on overt heart failure. This evidence concerns the gene MME and heart failure.